Please use this identifier to cite or link to this item:
PIRA download icon_1.1View/Download Full Text
DC FieldValueLanguage
dc.contributorDepartment of Applied Biology and Chemical Technology-
dc.creatorChow, LMCen_US
dc.creatorChan, THen_US
dc.creatorChan, KFen_US
dc.creatorWong, ILKen_US
dc.creatorLaw, MCen_US
dc.rightsAssignee: The Hong Kong Polytechnic Universityen_US
dc.rightsAssignee: The Royal Institution for the Advancement of Learning/McGill Universityen_US
dc.titleAlkyne-, azide- and triazole-containing flavonoids as modulators for multidrug resistance in cancersen_US
dc.description.otherinformationUS10208025; US10208025 B2; US10208025B2; US10,208,025; US10,208,025 B2; 10208025; Appl. No. 15/296,471en_US
dcterms.abstractA triazole bridged flavonoid dimer compound library was efficiently constructed via the cycloaddition reaction of a series of flavonoid-containing azides (Az 1-15) and alkynes (Ac 1-17). These triazole bridged flavonoid dimers and their precursor alkyne- and azide-containing flavonoids were screened for their ability to modulate multidrug resistance (MDR) in P-gp-overexpressed cell line (LCC6MDR), MRP1-overexpressed cell line (2008/MRP1) and BCRP-overexpressed cell line (HEK293/R2 and MCF7-MX100). Generally, they displayed very promising MDR reversal activity against P-gp-, MRP1- and BCRP-mediated drug resistance. Moreover, they showed different levels of selectivity for various transporters. Overall, they can be divided into mono-selective, dual-selective and multi-selective modulators for the P-gp, MRP1 and BCRP transporters. The EC.sub.50 values for reversing paclitaxel resistance (141-340 nM) of LCC6MDR cells, DOX (78-590 nM) and vincristine (82-550 nM) resistance of 2008/MRP1 cells and topotecan resistance (0.9-135 nM) of HEK293/R2 and MCF7-MX100 cells were at nanomolar range. Importantly, a number of compounds displayed EC.sub.50 at or below 10 nM in BCRP-overexpressed cell lines, indicating that these bivalent triazoles more selectively inhibit BCRP transporter than the P-gp and MRP1 transporters. Most of the dimers are notably safe MDR chemosensitizers as indicated by their high therapeutic index values.-
dcterms.bibliographicCitationUS Patent 10,208,025 B2. Washington, DC: US Patent and Trademark Office, 2019.en_US
dc.description.validate202006 bcrc-
dc.description.oaVersion of Recorden_US
Appears in Collections:Patent
Files in This Item:
File Description SizeFormat 
us10208025b2.pdf5.73 MBAdobe PDFView/Open
Show simple item record

Page views

Citations as of Jun 19, 2022


Citations as of Jun 19, 2022

Google ScholarTM


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.